Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
NCT00464672
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1893
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza virus vaccine
BIOLOGICAL:
Comparator influenza vaccine
Sponsor
Novartis
Collaborators
[object Object]